Detalhe da pesquisa
1.
Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study.
J Neurol Neurosurg Psychiatry
; 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38569872
2.
Risk of secondary progressive multiple sclerosis after early worsening of disability.
J Neurol Neurosurg Psychiatry
; 94(12): 984-991, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414538
3.
Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial.
J Neurol Neurosurg Psychiatry
; 94(12): 1004-1011, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414534
4.
Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis.
Mult Scler
; 29(7): 875-883, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36851894
5.
Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis.
Eur J Neurol
; 30(4): 1014-1024, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36692895
6.
Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS.
Mult Scler
; 28(11): 1752-1761, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35373638
7.
Confirmed disability progression as a marker of permanent disability in multiple sclerosis.
Eur J Neurol
; 29(8): 2321-2334, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35582938
8.
Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis.
Mult Scler
; 27(5): 755-766, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32538713
9.
Determinants of therapeutic lag in multiple sclerosis.
Mult Scler
; 27(12): 1838-1851, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33423618
10.
Risk of secondary progressive multiple sclerosis: A longitudinal study.
Mult Scler
; 26(1): 79-90, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31397221
11.
Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis.
Mult Scler
; 24(5): 642-652, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28382837
12.
Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.
Brain
; 140(9): 2426-2443, 2017 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29050389
13.
Predictors of long-term disability accrual in relapse-onset multiple sclerosis.
Ann Neurol
; 80(1): 89-100, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27145331
14.
Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 88(3): 196-203, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27683916
15.
Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice.
Mult Scler
; 23(10): 1346-1357, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27885062
16.
Contribution of different relapse phenotypes to disability in multiple sclerosis.
Mult Scler
; 23(2): 266-276, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27055805
17.
Defining secondary progressive multiple sclerosis.
Brain
; 139(Pt 9): 2395-405, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27401521
18.
Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study.
J Neurol Neurosurg Psychiatry
; 87(10): 1133-7, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27298148
19.
Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 87(12): 1343-1349, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27810919
20.
The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis.
Mult Scler
; 22(4): 520-32, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26199347